The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD
Conditions
- Alzheimer Disease
- Dementia
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Tauopathies
- Neurodegenerative Diseases
- Delirium, Dementia, Amnestic, Cognitive Disorders
- Mental Disorders
Interventions
- BIOLOGICAL: NEUROSTEM®-AD
Sponsor
Duk Lyul Na
Collaborators